Detection of group A streptococcus in children with confirmed viral pharyngitis and antiviral host response
暂无分享,去创建一个
Niina Putkuri | V. Peltola | K. Rantakokko-jalava | J. Niemelä | M. Waris | J. Vuopio | T. Vuorinen | Lauri Ivaska | K. Gröndahl-Yli-Hannuksela
[1] Mohamed Yahya,et al. Myxovirus Resistance Protein A as a Marker of Viral Cause of Illness in Children Hospitalized with an Acute Infection , 2022, Microbiology spectrum.
[2] R. Link-Gelles,et al. Incidence of pharyngitis, sinusitis, acute otitis media, and outpatient antibiotic prescribing preventable by vaccination against group A Streptococcus in the United States. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] Mohamed Yahya,et al. Prevalence of respiratory viruses and antiviral MxA responses in children with febrile urinary tract infection , 2020, European Journal of Clinical Microbiology & Infectious Diseases.
[4] A. Ralph,et al. Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study , 2019, Open forum infectious diseases.
[5] R. Tanz,et al. Caution Needed: Molecular Diagnosis of Pediatric Group A Streptococcal Pharyngitis , 2018, Journal of the Pediatric Infectious Diseases Society.
[6] P. Jaggi,et al. Molecular Testing for Group A Streptococcal Pharyngitis: To Test or Not To Test, That Is the Question. , 2018, Journal of the Pediatric Infectious Diseases Society.
[7] M. Baker,et al. Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis , 2018, PLoS neglected tropical diseases.
[8] Daniel J. Shapiro,et al. Viral Features and Testing for Streptococcal Pharyngitis , 2017, Pediatrics.
[9] J. Lempainen,et al. Aetiology of febrile pharyngitis in children: Potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection , 2017, Journal of Infection.
[10] Jason G. Newland,et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. , 2016, JAMA.
[11] V. Pascual,et al. Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis. , 2016, American journal of respiratory and critical care medicine.
[12] K. Irjala,et al. Detection of Group A Streptococcus from Pharyngeal Swab Samples by Bacterial Culture Is Challenged by a Novel mariPOC Point-of-Care Test , 2015, Journal of Clinical Microbiology.
[13] D. Hober,et al. Diagnosis of Viral Infections Using Myxovirus Resistance Protein A (MxA) , 2015, Pediatrics.
[14] S. Gokahmetoglu,et al. Sore throat in primary care project: a clinical score to diagnose viral sore throat , 2015, Family practice.
[15] J. Ilonen,et al. Blood MxA protein as a marker for respiratory virus infections in young children , 2014, Journal of Clinical Virology.
[16] Daniel J. Shapiro,et al. Overprescribing and inappropriate antibiotic selection for children with pharyngitis in the United States, 1997-2010. , 2014, JAMA pediatrics.
[17] H. Drexhage,et al. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome , 2013, Annals of the rheumatic diseases.
[18] P. Kovarik,et al. Type I Interferon Production Induced by Streptococcus pyogenes-Derived Nucleic Acids Is Required for Host Protection , 2011, PLoS pathogens.
[19] N. Shaikh,et al. Prevalence of Streptococcal Pharyngitis and Streptococcal Carriage in Children: A Meta-analysis , 2010, Pediatrics.
[20] S. Olmsted,et al. The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection. , 2009, FEMS immunology and medical microbiology.
[21] O. Ruuskanen,et al. Identification of Respiratory Viruses in Asymptomatic Subjects: Asymptomatic Respiratory Viral Infections , 2008, The Pediatric infectious disease journal.
[22] I. Julkunen,et al. Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll‐like receptor (TLR) gene expression in human primary macrophages , 2008, Journal of leukocyte biology.
[23] J. Ilonen,et al. MxA protein assay for optimal monitoring of IFN‐β bioactivity in the treatment of MS patients , 2008, Acta neurologica Scandinavica.